아미쿠스 테라 (FOLD)

Nov 20, 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Victory Capital Management Inc. - MarketBeat

Nov 20, 2024

Nov 19, 2024

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap DownShould You Sell? - MarketBeat

Nov 19, 2024

Nov 16, 2024

Amicus Therapeutics (NASDAQ:FOLD) Rating Increased to Buy at StockNews.com - MarketBeat

Nov 16, 2024

Nov 15, 2024

Redmile Group, LLC Increases Stake in Amicus Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Protein Therapeutics Market Size to be Worth USD 549.4 billion by 2031, at a CAGR of 6.3% | Transparency Market Research, Inc. - GlobeNewswire Inc.

Nov 15, 2024

Nov 14, 2024

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC Acquires Shares in Amic - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated - MSN

Nov 14, 2024

Nov 14, 2024

Avoro Capital Advisors LLC Adjusts Stake in Amicus Therapeutics Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Purchased by GSA Capital Partners LLP - MarketBeat

Nov 14, 2024

Nov 12, 2024

A Closer Look at 8 Analyst Recommendations For Amicus Therapeutics - Benzinga

Nov 12, 2024

Nov 12, 2024

The Analyst Verdict: Amicus Therapeutics In The Eyes Of 8 Experts - Benzinga

Nov 12, 2024

Nov 12, 2024

Amicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings) - Benzinga

Nov 12, 2024

Nov 12, 2024

Amicus Therapeutics (NASDAQ:FOLD) Price Target Raised to $17.00 - MarketBeat

Nov 12, 2024

Nov 10, 2024

FOLDAmicus Therapeutics, Inc Latest Stock News & Market Updates - StockTitan

Nov 10, 2024

Nov 10, 2024

Here's Why Amicus Therapeutics (NASDAQ:FOLD) Has A Meaningful Debt Burden - Simply Wall St

Nov 10, 2024

Nov 09, 2024

Fiera Capital Corp Reduces Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Nov 09, 2024

Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition in Amicu - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Amicus Therapeutics CEO Campbell sells $98,800 in stock - Investing.com India

Nov 08, 2024

Nov 08, 2024

Amicus Therapeutics CEO Campbell sells $98,800 in stock By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Amicus Therapeutics (NASDAQ:FOLD) Downgraded by StockNews.com to Hold - MarketBeat

Nov 08, 2024

Nov 07, 2024

Amicus Therapeutics (NASDAQ:FOLD) Given New $15.00 Price Target at Guggenheim - MarketBeat

Nov 07, 2024

Nov 07, 2024

Teva’s Galafold generic for Fabry disease may be available in US - Fabry Disease News

Nov 07, 2024

Nov 07, 2024

Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Needham & Company LLC Reiterates Hold Rating for Amicus Therapeutics (NASDAQ:FOLD) - MarketBeat

Nov 07, 2024

Nov 07, 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 07, 2024

Peeling Back The Layers: Exploring Amicus Therapeutics Through Analyst Insights - Benzinga

Nov 07, 2024

Nov 06, 2024

Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Earnings call: Amicus Therapeutics reports robust Q3 growth, raises guidance - Investing.com India

Nov 06, 2024

Nov 06, 2024

Earnings call: Amicus Therapeutics reports robust Q3 growth, raises guidance By Investing.com - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Amicus Therapeutics Q3 2024 Earnings Preview - MSN

Nov 06, 2024

Nov 06, 2024

Old West Investment Management LLC Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Nov 06, 2024

Nov 06, 2024

Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance

Nov 06, 2024

Nov 06, 2024

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings: Revenue Surges - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Amicus Therapeutics: Q3 Earnings Snapshot - San Antonio Express-News

Nov 06, 2024

Nov 06, 2024

Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates - The Manila Times

Nov 06, 2024

Nov 05, 2024

Creative Planning Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

Nov 05, 2024

Nov 04, 2024

Bradley L. Campbell Sells 7,500 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock - MarketBeat

Nov 04, 2024

Nov 04, 2024

Amicus Therapeutics CEO Bradley Campbell sells $85,959 in stock By Investing.com - Investing.com Canada

Nov 04, 2024

Nov 04, 2024

Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know - MSN

Nov 04, 2024

Nov 04, 2024

Allspring Global Investments Holdings LLC Has $172,000 Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

Nov 04, 2024

Nov 04, 2024

Brokerages Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $17.13 - Defense World

Nov 04, 2024

Nov 03, 2024

Blue Trust Inc. Boosts Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

Nov 03, 2024

Nov 01, 2024

Cradle of Cures - Site Selection Magazine

Nov 01, 2024

Nov 01, 2024

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024 - GlobeNewswire

Nov 01, 2024

Nov 01, 2024

Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $17.13 - MarketBeat

Nov 01, 2024

Nov 01, 2024

abrdn plc Boosts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Nov 01, 2024

Oct 31, 2024

Amicus Therapeutics (NASDAQ:FOLD) Stock Rating Lowered by StockNews.com - Defense World

Oct 31, 2024

Oct 30, 2024

Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Oct 30, 2024

Oct 30, 2024

Amicus Therapeutics (FOLD) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2024